Welcome to Alfred Nobels allé

On Alfred Nobels Allé, a thriving life science cluster is rapidly gaining strength. With prime land ready for development and a bold vision for the future, Flemingsberg and Alfred Nobels allé is where ideas become reality.

Strategically located near one of Europe’s largest university hospitals and the prestigious Karolinska Institutet, Flemingsberg is home to Sweden’s eighth-largest campus. It unites five colleges and universities, an art school, and a high school, creating a dynamic multi-university environment where higher education, cutting-edge research, and industry flourish together.

Botkyrka Municipality offers three prime locations along Alfred Nobels allé: Biologen 6, 7, and 9. These provide approximately 10,800 square meters of space for offices and industrial development.

“Botkyrka offers establishment opportunities for companies that want to customize their own premises. One of the companies that has already established itself here is SmartCella, an innovative company developing groundbreaking cell and mRNA therapies, including a heart stem cell therapy to repair heart tissue damaged after a heart attack.” – Mariam Yousif Baythoon, Business Strategist at Botkyrka Municipality.

Become part of a hub of knowledge-driven companies and a robust Life Science cluster. Join one of Sweden’s largest urban development projects and help shape the future.

Because in Flemingsberg, anything is possible.

Secure your place in this thriving Life Science ecosystem today.

Read more about Alfred Nobels allé >

Building a heart: Realheart aims to create new opportunities for patients with heart failure

A mechanical heart, as close to a human heart as it gets. Realheart is the company developing a total artificial heart for patients with advanced heart failure, a condition where treatment options are often limited. When we sit down with CEO Ina Laura Perkins, she tells the story of an innovation that has taken its time, about the strong drive to reach all the way to patients, and about steps that are bringing the company closer to clinical reality.

Go to Top